2023-09-11 16:12:13 ET
More on Crinetics Pharmaceuticals
- Seeking Alpha’s Quant Rating on Crinetics Pharmaceuticals
- Historical earnings data for Crinetics Pharmaceuticals
- Financial information for Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals: Creating Next-Generation Treatments In Acromegaly
- Crinetics Pharmaceuticals: Paltusotine Phase 3 Data Presented At ENDO
- Biggest stock movers today: Tesla, Qualcomm, J.M. Smucker and more
- Crinetics climbs as lead asset succeeds in Phase 3 trial for acromegaly
- Crinetics rated Outperform at Oppenheimer on upcoming Phase 3 data
For further details see:
Crinetics Pharmaceuticals announces proposed public offering of common stock